PDF herunterladen
Semin Liver Dis 2021; 41(02): 206-212
DOI: 10.1055/s-0041-1728663
Review Article

Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine

Carol J. Soroka
1   Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
,
Scott J. Roberts
1   Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
,
James L. Boyer
1   Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
,
David N. Assis
1   Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
› Institutsangaben Funding Gilead Sciences, PSC Partners Seeking a Cure, Yale Liver Center
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Translational studies in human cholestatic diseases have for years been hindered by various challenges, including the rarity of the disorders, the difficulty in obtaining biliary tissue from across the spectrum of the disease stage, and the difficulty culturing and maintaining primary cholangiocytes. Organoid technology is increasingly being viewed as a technological breakthrough in translational medicine as it allows the culture and biobanking of self-organizing cells from various sources that facilitate the study of pathophysiology and therapeutics, including from individual patients in a personalized approach. This review describes current research using biliary organoids for the study of human cholestatic diseases and the emerging applications of organoids to regenerative medicine directed at the biliary tree. Challenges and possible solutions to the current hurdles in this emerging field, particularly the need for standardization of terminology and clarity on source materials and techniques, are also discussed.

Keywords

organoids - biliary - cholestasis - stem cell - cholangiopathy - regenerative medicine


Publikationsverlauf

Artikel online veröffentlicht:
06. Mai 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Clevers H. Modeling development and disease with organoids. Cell 2016; 165 (07) 1586-1597
    CrossrefPubMedGoogle Scholar
  • 2 Alpini G, McGill JM, Larusso NF. The pathobiology of biliary epithelia. Hepatology 2002; 35 (05) 1256-1268
    CrossrefPubMedGoogle Scholar
  • 3 Marzioni M, Glaser SS, Francis H, Phinizy JL, LeSage G, Alpini G. Functional heterogeneity of cholangiocytes. Semin Liver Dis 2002; 22 (03) 227-240
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 4 Dong X, Zhang T, Liu Q. et al. Beneficial effects of urine-derived stem cells on fibrosis and apoptosis of myocardial, glomerular and bladder cells. Mol Cell Endocrinol 2016; 427: 21-32
    CrossrefPubMedGoogle Scholar
  • 5 Drost J, Clevers H. Translational applications of adult stem cell-derived organoids. Development 2017; 144 (06) 968-975
    CrossrefPubMedGoogle Scholar
  • 6 Vlachogiannis G, Hedayat S, Vatsiou A. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 2018; 359 (6378): 920-926
    CrossrefPubMedGoogle Scholar
  • 7 Ramalho AS, Fürstová E, Vonk AM. et al; Belgian Organoid Project. Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis. Eur Respir J 2021; 57 (01) 1902426
    CrossrefPubMedGoogle Scholar
  • 8 Chen KG, Zhong P, Zheng W, Beekman JM. Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids. Drug Discov Today 2019; 24 (11) 2126-2138
    CrossrefPubMedGoogle Scholar
  • 9 Huch M, Gehart H, van Boxtel R. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 2015; 160 (1–2): 299-312
    CrossrefPubMedGoogle Scholar
  • 10 Ogawa M, Ogawa S, Bear CE. et al. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat Biotechnol 2015; 33 (08) 853-861
    CrossrefPubMedGoogle Scholar
  • 11 Sampaziotis F, de Brito MC, Madrigal P. et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat Biotechnol 2015; 33 (08) 845-852
    CrossrefPubMedGoogle Scholar
  • 12 Wu F, Wu D, Ren Y. et al. Generation of hepatobiliary organoids from human induced pluripotent stem cells. J Hepatol 2019; 70 (06) 1145-1158
    CrossrefPubMedGoogle Scholar
  • 13 Hu H, Gehart H, Artegiani B. et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 2018; 175 (06) 1591.e19-1606.e19
    PubMedGoogle Scholar
  • 14 Sampaziotis F, Justin AW, Tysoe OC. et al. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids. Nat Med 2017; 23 (08) 954-963
    CrossrefPubMedGoogle Scholar
  • 15 Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120 (01) 117-130
    CrossrefPubMedGoogle Scholar
  • 16 Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol 2019; 16 (05) 269-281
    CrossrefPubMedGoogle Scholar
  • 17 Strazzabosco M, Fiorotto R, Cadamuro M. et al. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. Biochim Biophys Acta Mol Basis Dis 2018; 1864 (4, Pt B): 1374-1379
    CrossrefPubMedGoogle Scholar
  • 18 Loarca L, De Assuncao TM, Jalan-Sakrikar N. et al. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis. Lab Invest 2017; 97 (11) 1385-1396
    CrossrefPubMedGoogle Scholar
  • 19 Tabibian JH, O'Hara SP, Splinter PL, Trussoni CE, LaRusso NF. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis. Hepatology 2014; 59 (06) 2263-2275
    CrossrefPubMedGoogle Scholar
  • 20 Broutier L, Andersson-Rolf A, Hindley CJ. et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc 2016; 11 (09) 1724-1743
    CrossrefPubMedGoogle Scholar
  • 21 Sampaziotis F, de Brito MC, Geti I, Bertero A, Hannan NR, Vallier L. Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells. Nat Protoc 2017; 12 (04) 814-827
    CrossrefPubMedGoogle Scholar
  • 22 Soroka CJ, Assis DN, Boyer JL. Patient-derived organoids from human bile: an in vitro method to study cholangiopathies. Methods Mol Biol 2019; 1981: 363-372
    CrossrefPubMedGoogle Scholar
  • 23 Andersson ER, Chivukula IV, Hankeova S. et al. Mouse model of Alagille syndrome and mechanisms of jagged1 missense mutations. Gastroenterology 2018; 154 (04) 1080-1095
    CrossrefPubMedGoogle Scholar
  • 24 Guan Y, Xu D, Garfin PM. et al. Human hepatic organoids for the analysis of human genetic diseases. JCI Insight 2017; 2 (17) 94954
    CrossrefPubMedGoogle Scholar
  • 25 Bezerra JA, Wells RG, Mack CL. et al. Biliary atresia: clinical and research challenges for the twenty-first century. Hepatology 2018; 68 (03) 1163-1173
    CrossrefPubMedGoogle Scholar
  • 26 Harper P, Plant JW, Unger DB. Congenital biliary atresia and jaundice in lambs and calves. Aust Vet J 1990; 67 (01) 18-22
    CrossrefPubMedGoogle Scholar
  • 27 Waisbourd-Zinman O, Koh H, Tsai S. et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology 2016; 64 (03) 880-893
    CrossrefPubMedGoogle Scholar
  • 28 Amarachintha S, Mourya R, Ayabe H. et al. Patient-dervied cholangiocyte organoids point to defects in epithelial development in pathogenesis of biliary atresia. Hapatology. 2019; 70 (S1): 50A
    PubMedGoogle Scholar
  • 29 Soroka CJ, Assis DN, Alrabadi LS. et al. Bile-derived organoids from patients with primary sclerosing cholangitis recapitulate their inflammatory immune profile. Hepatology 2019; 70 (03) 871-882
    CrossrefPubMedGoogle Scholar
  • 30 Oo YH, Banz V, Kavanagh D. et al. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J Hepatol 2012; 57 (05) 1044-1051
    CrossrefPubMedGoogle Scholar
  • 31 Brevini T, Tysoe OC, Sampaziotis F. Tissue engineering of the biliary tract and modelling of cholestatic disorders. J Hepatol 2020; 73 (04) 918-932
    CrossrefPubMedGoogle Scholar
  • 32 Chen C, Jochems PGM, Salz L. et al. Bioengineered bile ducts recapitulate key cholangiocyte functions. Biofabrication 2018; 10 (03) 034103
    CrossrefPubMedGoogle Scholar
  • 33 Acun A, Oganesyan R, Uygun BE. Liver bioengineering: promise, pitfalls, and hurdles to overcome. Curr Transplant Rep 2019; 6 (02) 119-126
    CrossrefPubMedGoogle Scholar
  • 34 Ogiso S, Yasuchika K, Fukumitsu K. et al. Efficient recellularisation of decellularised whole-liver grafts using biliary tree and foetal hepatocytes. Sci Rep 2016; 6: 35887
    CrossrefPubMedGoogle Scholar
  • 35 Mazza G, Rombouts K, Rennie Hall A. et al. Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep 2015; 5: 13079
    CrossrefPubMedGoogle Scholar
  • 36 Chen Y, Devalliere J, Bulutoglu B, Yarmush ML, Uygun BE. Repopulation of intrahepatic bile ducts in engineered rat liver grafts. Technology (Singap World Sci) 2019; 7 (1–2): 46-55
    PubMedGoogle Scholar
  • 37 Boyer CJ, Boktor M, Samant H. et al. 3D printing for bio-synthetic biliary stents. Bioengineering (Basel) 2019; 6 (01) E16
    CrossrefPubMedGoogle Scholar
  • 38 Takebe T, Zhang B, Radisic M. Synergistic engineering: organoids meet organs-on-a-chip. Cell Stem Cell 2017; 21 (03) 297-300
    CrossrefPubMedGoogle Scholar
  • 39 Du Y, Khandekar G, Llewellyn J, Polacheck W, Chen CS, Wells RG. A bile duct-on-a-chip with organ-level functions. Hepatology 2020; 71 (04) 1350-1363
    CrossrefPubMedGoogle Scholar
  • 40 Broguiere N, Isenmann L, Hirt C. et al. Growth of epithelial organoids in a defined hydrogel. Adv Mater 2018; 30 (43) e1801621
    CrossrefPubMedGoogle Scholar
  • 41 Liu H, Wang Y, Cui K, Guo Y, Zhang X, Qin J. Advances in hydrogels in organoids and organs-on-a-chip. Adv Mater 2019; 31 (50) e1902042
    CrossrefPubMedGoogle Scholar
  • 42 Saheli M, Sepantafar M, Pournasr B. et al. Three-dimensional liver-derived extracellular matrix hydrogel promotes liver organoids function. J Cell Biochem 2018; 119 (06) 4320-4333
    CrossrefPubMedGoogle Scholar
  • 43 Yin YB, de Jonge HR, Wu X, Yin YL. Mini-gut: a promising model for drug development. Drug Discov Today 2019; 24 (09) 1784-1794
    CrossrefPubMedGoogle Scholar
  • 44 Koike H, Iwasawa K, Ouchi R. et al. Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary. Nature 2019; 574 (7776): 112-116
    CrossrefPubMedGoogle Scholar
  • 45 Takebe T, Sekine K, Enomura M. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013; 499 (7459): 481-484
    CrossrefPubMedGoogle Scholar
  • 46 Cameron RG, Blendis LM, Neuman MG. Accumulation of macrophages in primary sclerosing cholangitis. Clin Biochem 2001; 34 (03) 195-201
    CrossrefPubMedGoogle Scholar
  • 47 Soroka CJ, Roberts R, Hohenester SD, Boyer JL, Assiss DN. AS055 - Co-culture of bile-derived organoids from primary sclerosing cholangitis patients with CD4+ T cells replicates pathogenic, CCL20 dependent biliary-immune interactions. J Hepatol 2020; 73 (01) S41
    CrossrefPubMedGoogle Scholar
  • 48 Kunzmann LK, Schoknecht T, Poch T. et al. Monocytes as potential mediators of pathogen-induced Th17 differentiation in patients with primary sclerosing cholangitis (PSC). Hepatology 2020; (e-pub ahead of print) DOI: 10.1002/hep.31140.
    CrossrefPubMedGoogle Scholar